MedTrace Logo

Prospective Safety and Tolerability Assessment of a Cardiovascular Health Dietary Supplement

NCT02452749 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-03-15

No results posted yet for this study

Summary

This single-arm, open-label study will assess the safety and tolerability of one daily tablet of a commercially available cardiovascular health dietary supplement by questionnaire and blood markers in adults with borderline to mild hypertension over a 6 month period. Although the cardiovascular health dietary supplement being investigated has been on the market for over 20 years, prospective safety data and blood markers of end organ function have not previously been reported.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cardiovascular health dietary supplement

Herbal/mineral dietary supplement

Sponsors & Collaborators

  • National University of Natural Medicine

    lead OTHER

Principal Investigators

  • Jennifer J Ryan, ND, MS · National University of Natural Medicine

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-01
Primary Completion
2017-07-28
Completion
2017-07-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452749 on ClinicalTrials.gov